Advances of insulin-like growth factor Ⅰ signaling pathway and therapeutic target of breast cancer

doi:10.3969/j.issn.1674-8115.2014.05.035

Abstract

Abstract:

The insulin-like growth factor Ⅰ (IGF-Ⅰ) signaling pathway has been found to be closely related to the therapeutic effect of breast cancer. Researches on using the IGF-Ⅰ as a new target for the target therapy of breast cancer have attracted more and more attention. Pre-clinical studies or clinical tests have been conducted for relevant targeted drugs and showed good prospect of basic researches and clinical applications. This paper reviews targeted drugs and research developments of IGF-Ⅰ.

Key words: breast cancer, insulin-like growth factor Ⅰ signaling pathway, target therapy

LIANG Yue, CHEN Xiao-song, SHEN Kun-wei. Advances of insulin-like growth factor Ⅰ signaling pathway and therapeutic target of breast cancer[J]. , doi: 10.3969/j.issn.1674-8115.2014.05.035.

[1]	Jia-ling ZHANG, Feng-chun ZHANG, Ying-chun XU. Research progress in the systemic treatment for breast cancer with brain metastasis [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(5): 671-677.
[2]	Xiao-jun ZHAO, Zhi-gang QIAO, Ting-yu LIANG, Yan-ling AN. Expression of breast cancer susceptibility gene 1 protein in brain gliomas and its influence on the sensitivity of temozolomide [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(1): 118-122.
[3]	CHEN Si, LIU Chun-liang, ZHAO Qian, SUN Hai-peng, LIU Yun-xia. Identification of hub genes and key pathways in breast cancersurvival-based bioinformatics analysis [J]. , 2020, 40(3): 294-.
[4]	YE Xin, ZHOU Xiao-yun, YANG Li, WANG Jie, HE Qi. Analysis of clinicopathological features and prognosis of young patients with breast cancer in different age groups [J]. , 2020, 40(3): 351-.
[5]	CHENG Long, XU Wu-qin, ZHANG Peng, HUANG Jian-jun, LI Xiao-ning. Effect of miR-27a down-regulation on proliferation, migration and invasion in triple-negative breast cancer cells [J]. , 2020, 40(2): 188-.
[6]	ZHANG Feng-chun, ZHANG Shuo-yuan, CHEN Tian-en, XU Ying-chun. Clinical application of PD-1/PD-L1 to prognosis prediction and treatment of triple-negative breast cancer [J]. , 2020, 40(1): 128-.
[7]	HE Qin, ZHANG Wei-bin, SHEN Yu-hui. Establishment of a prognostic scoring model for the breast cancer patients with spinal metastasis [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2020, 40(09): 1243-1248.
[8]	LIU Jie, QIU Xiao-chun. Research hotspots and trends of breast cancer stem cells [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2020, 40(07): 881-888.
[9]	LU Yu-jie, JIN Ze-yu, LI Ya-fen, SHEN Kun-wei, CHEN Wei-guo, CHEN Xiao-song. Receptor status testing and its influence on following treatment selection in breast cancer patients with loco-regional recurrence [J]. , 2019, 39(9): 1071-.
[10]	GU Xiao-ping1, CHEN Meng-ping1, LIANG A-juan2, LIU Yun-xia1, SUN Hai-peng1, HUANG Ying1. Regulation of mitochondrial carrier SLC25A13 on breast cancer cell cycle in vitro [J]. , 2019, 39(8): 848-.
[11]	SUN Xiao-yin, ZHUANG Zhi-gang, FU Yun, CHENG Xiao-lin. Analysis of X-ray signs and postoperative pathological features of breast cancer [J]. , 2019, 39(4): 398-.
[12]	DONG Xiao-jing1, ZHANG Nan1, GAN Lu1, WU Yi-ying1, CHEN Yun-yun1, FANG Qiong2. Compliance analysis of adjuvant therapy in elderly patients with breast cancer under case-management model [J]. , 2019, 39(2): 170-.
[13]	WANG Zhi-wei, WANG Jie, WEI Min, YANG Li, SHAO Yu-guo, JI Min, HE Qi. Comparison of therapeutic effects between different cycles of docetaxel, epirubicin and cyclophosphamide regime on adjuvant chemotherapy of locally advanced breast cancer [J]. , 2019, 39(12): 1432-.
[14]	FANG Qiong1, CHEN Yun-yun1, DONG Xiao-jing1, ZHAGN Nan1, SHEN Kun-Wei1, WU Bei-wen2. Impact of body weight and physical activity on quality of life among breast cancer patients receiving adjuvant chemotherapy [J]. , 2018, 38(9): 1079-.
[15]	YUAN Xiao-ling1, YOU Jing-rong1, SHEN Li-li2, LI Su-yun3, SHEN Dan-wei4, CAI Ling-zhi5, CHEN Ying-dan1, ZHU Han-jing1, YUAN Chang-rong6. Study on the predictors of the menopausal symptoms related quality of life in patients with breast cancer undergoing chemotherapy [J]. , 2018, 38(12): 1457-.

Advances of insulin-like growth factor Ⅰ signaling pathway and therapeutic target of breast cancer

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

TrendMD

References

Related Articles 15

Recommended Articles

Metrics

Comments